In January-June 2012, the company posted net profit of RON25.73 million.
Antibiotice reported sales of RON141.85 million in the first six months of 2013, down 4.3% from RON148.2 million in the year-ago period.
However, the company’s exports rose 30% on the year to RON43.7 million, Antibiotice said in its financial report.
Operating profit fell 29.4% to RON23.22 million, from RON32.9 million in the first half of 2012.
For the whole of 2013, Antibiotice estimates a net profit of RON28.56 million, up from RON27.1 million in the previous year. Sales are expected to rise 3.6% to RON315 million.
Antibiotice is majority-owned by Romania’s Health Ministry, with a 53% stake, while investment fund SIF Oltenia (SIF5.RO) holds a 10% stake.
Tuesday, Antibiotice closed down 0.13% at RON0.4689 a share in Bucharest. (EUR1=RON4.4278)